Literature DB >> 1845931

Granulocyte-macrophage colony-stimulating factor and interleukin-3 induce rapid phosphorylation and activation of the proto-oncogene Raf-1 in a human factor-dependent myeloid cell line.

Y Kanakura1, B Druker, K W Wood, H J Mamon, K Okuda, T M Roberts, J D Griffin.   

Abstract

The product of the c-raf-1 proto-oncogene, Raf-1, is a 74,000-dalton cytoplasmic serine/threonine protein kinase that has been implicated as an intermediate in signal transduction mechanisms. In the human factor-dependent myeloid cell line MO7, both granulocyte-macrophage colony stimulating factor (GM-CSF) and interleukin-3 (IL-3) were found to induce rapid, dose-dependent phosphorylation of Raf-1, which resulted in altered Raf-1 mobility in sodium dodecyl sulfate-polyacrylamide gels. The increase in phosphorylation was due primarily to an increase in phosphoserine, with only a minor component (less than 2%) of phosphotyrosine. PMA (12-phorbol 13-myristic acid) also induced Raf-1 phosphorylation in MO7 cells, but the resulting alteration in electrophoretic mobility was different than that observed after GM-CSF or IL-3. GM-CSF and IL-3 rapidly and transiently increased Raf-1 kinase activity using Histone H1 as a substrate in an immune complex kinase assay in vitro. These results suggest that phosphorylation of Raf-1 could play a role in some aspect of GM-CSF and IL-3 signal transduction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845931

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway.

Authors:  W Popik; P M Pitha
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

Review 2.  Cellular signalling mechanisms in B lymphocytes.

Authors:  W Cushley; M M Harnett
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

3.  KSR1 is a functional protein kinase capable of serine autophosphorylation and direct phosphorylation of MEK1.

Authors:  Jeremy A Goettel; Dongchun Liang; Valda C Hilliard; Karen L Edelblum; Matthew R Broadus; Kathleen L Gould; Steven K Hanks; D Brent Polk
Journal:  Exp Cell Res       Date:  2010-12-07       Impact factor: 3.905

4.  Interleukin 2 regulates Raf-1 kinase activity through a tyrosine phosphorylation-dependent mechanism in a T-cell line.

Authors:  B C Turner; N K Tonks; U R Rapp; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

5.  TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k).

Authors:  D E Montenegro; T Franklin; L C Moscinski; K S Zuckerman; X-T Hu
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

6.  Expression patterns of Raf-1 suggest multiple roles in tooth development.

Authors:  M Sunohara; H Tanzawa; Y Kaneko; A Fuse; K Sato
Journal:  Calcif Tissue Int       Date:  1996-01       Impact factor: 4.333

7.  Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.

Authors:  J R Fabian; I O Daar; D K Morrison
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

8.  Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis.

Authors:  O Miura; A D'Andrea; D Kabat; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

9.  The alpha subunit of the human granulocyte-macrophage colony-stimulating factor receptor signals for glucose transport via a phosphorylation-independent pathway.

Authors:  D X Ding; C I Rivas; M L Heaney; M A Raines; J C Vera; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

Review 10.  Signal transduction pathways involving the Raf proto-oncogene.

Authors:  N G Williams; T M Roberts
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.